Tony Lai

467 total citations
17 papers, 148 citations indexed

About

Tony Lai is a scholar working on Pharmacology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Tony Lai has authored 17 papers receiving a total of 148 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 7 papers in Epidemiology and 6 papers in Infectious Diseases. Recurrent topics in Tony Lai's work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Antifungal resistance and susceptibility (4 papers) and Pneumonia and Respiratory Infections (3 papers). Tony Lai is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (6 papers), Antifungal resistance and susceptibility (4 papers) and Pneumonia and Respiratory Infections (3 papers). Tony Lai collaborates with scholars based in Australia, United States and United Kingdom. Tony Lai's co-authors include Amanda Gwee, Penelope A Bryant, Philip N Britton, Christopher C. Blyth, C Cooper, Alison Kesson, David Isaacs, Joshua Francis, Minyon Avent and Joshua Osowicki and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and British Journal of Clinical Pharmacology.

In The Last Decade

Tony Lai

15 papers receiving 146 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tony Lai Australia 6 59 51 45 40 27 17 148
Guillermo Martín-Gutiérrez Spain 8 26 0.4× 108 2.1× 30 0.7× 48 1.2× 11 0.4× 32 208
Anselm Jorda Austria 9 50 0.8× 81 1.6× 128 2.8× 23 0.6× 13 0.5× 33 271
Kathryn Daveson Australia 11 55 0.9× 146 2.9× 168 3.7× 85 2.1× 23 0.9× 15 302
Caroline Chen Australia 9 125 2.1× 62 1.2× 66 1.5× 83 2.1× 20 0.7× 16 304
Rafael Luque‐Márquez Spain 9 96 1.6× 99 1.9× 79 1.8× 31 0.8× 23 0.9× 25 206
Nikolas Rae United Kingdom 8 72 1.2× 83 1.6× 74 1.6× 49 1.2× 51 1.9× 15 202
Eleni Volakli Greece 9 84 1.4× 100 2.0× 20 0.4× 23 0.6× 26 1.0× 17 214
Mathieu Genuini France 6 120 2.0× 68 1.3× 28 0.6× 32 0.8× 11 0.4× 14 163
Kathryn Timberlake Canada 6 27 0.5× 34 0.7× 27 0.6× 29 0.7× 23 0.9× 20 109
Reenu Thomas South Africa 8 36 0.6× 93 1.8× 46 1.0× 20 0.5× 44 1.6× 19 181

Countries citing papers authored by Tony Lai

Since Specialization
Citations

This map shows the geographic impact of Tony Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tony Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tony Lai more than expected).

Fields of papers citing papers by Tony Lai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tony Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tony Lai. The network helps show where Tony Lai may publish in the future.

Co-authorship network of co-authors of Tony Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Tony Lai. A scholar is included among the top collaborators of Tony Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tony Lai. Tony Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Gwee, Amanda, et al.. (2025). Safe and effective use of vancomycin. Australian Prescriber. 48(2). 54–59. 1 indexed citations
2.
Duffull, Stephen B., Shivanthan Shanthikumar, Sarath Ranganathan, et al.. (2025). Personalized tobramycin dosing in children with cystic fibrosis: an AUC 24 -guided approach. Antimicrobial Agents and Chemotherapy. 69(9). e0027825–e0027825.
3.
Lai, Tony, et al.. (2024). Blame COVID! A case of tacrolimus toxicity managed with phenytoin. Pathology. 56. S88–S88.
4.
Callender, Librada, Tony Lai, Simon Driver, et al.. (2024). The Interaction of Opiate Misuse and Marijuana Use on Behavioral Health Outcomes Using the Traumatic Brain Injury Model Systems Pain Collaborative Dataset. Journal of Head Trauma Rehabilitation. 39(1). 82–93. 1 indexed citations
5.
Lai, Tony, M. Stokes, Hannah Yejin Kim, et al.. (2024). Therapeutic drug monitoring of liposomal amphotericin B in children. Are we there yet? A systematic review. Journal of Antimicrobial Chemotherapy. 79(4). 703–711. 1 indexed citations
6.
Zhu, Qiang, et al.. (2024). A piggyback method to collect statistics for query optimization in database management systems. Deep Blue (University of Michigan). 25. 1 indexed citations
7.
Lai, Tony, Xiao Zhu, Srinivas Bolisetty, et al.. (2023). Individualized vancomycin dosing in infants: prospective evaluation of an online dose calculator. International Journal of Antimicrobial Agents. 61(3). 106728–106728. 1 indexed citations
8.
Yeoh, Daniel K., Asha C Bowen, Philip N Britton, et al.. (2023). A multicentre, retrospective audit of fosfomycin use for urinary tract infections in Australian children and adolescents. Journal of Antimicrobial Chemotherapy. 78(7). 1616–1621. 3 indexed citations
9.
Lai, Tony, et al.. (2023). Exploring the advancements of Australian OPAT. Therapeutic Advances in Infectious Disease. 10. 2018434398–2018434398. 3 indexed citations
10.
Yeoh, Daniel K., Gabrielle M. Haeusler, Brendan McMullan, et al.. (2022). Antifungal use in children with acute leukaemia: state of current evidence and directions for future research. Journal of Antimicrobial Chemotherapy. 77(6). 1508–1524. 10 indexed citations
11.
Imani, Sahand, Dominic A. Fitzgerald, Paul D. Robinson, et al.. (2022). Personalized tobramycin dosing in children with cystic fibrosis: a comparative clinical evaluation of log-linear and Bayesian methods. Journal of Antimicrobial Chemotherapy. 77(12). 3358–3366. 4 indexed citations
12.
Lai, Tony, Jan‐Willem C. Alffenaar, Alison Kesson, Sushil Bandodkar, & Jason A. Roberts. (2019). Evaluation of target attainment of oral posaconazole suspension in immunocompromised children. Journal of Antimicrobial Chemotherapy. 75(3). 726–729. 16 indexed citations
13.
Huynh, Julie, Philip N Britton, C. Orla Morrissey, et al.. (2019). Endobronchial fusariosis in a child following bilateral lung transplant. Medical Mycology Case Reports. 23. 77–80. 5 indexed citations
14.
Stacey, Sonya, et al.. (2019). An evaluation of the user‐friendliness of Bayesian forecasting programs in a clinical setting. British Journal of Clinical Pharmacology. 85(10). 2436–2441. 28 indexed citations
15.
16.
Osowicki, Joshua, Amanda Gwee, Philip N Britton, et al.. (2015). Australia-wide Point Prevalence Survey of Antimicrobial Prescribing in Neonatal Units. The Pediatric Infectious Disease Journal. 34(8). e185–e190. 26 indexed citations
17.
Osowicki, Joshua, Amanda Gwee, Pamela Palasanthiran, et al.. (2014). Australia‐wide point prevalence survey of the use and appropriateness of antimicrobial prescribing for children in hospital. The Medical Journal of Australia. 201(11). 657–662. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guillermo Martín-Gutiérrez Breakdown of academic impact, for papers by Anselm Jorda Breakdown of academic impact, for papers by Kathryn Daveson Breakdown of academic impact, for papers by Caroline Chen Breakdown of academic impact, for papers by Rafael Luque‐Márquez Breakdown of academic impact, for papers by Nikolas Rae Breakdown of academic impact, for papers by Eleni Volakli Breakdown of academic impact, for papers by Mathieu Genuini Breakdown of academic impact, for papers by Kathryn Timberlake Breakdown of academic impact, for papers by Reenu Thomas
Rankless by CCL
2026